Janssen FDA Approves Janssen's Rybrevant, Guardant360 CDx for EGFR Exon 20-Mutated NSCLC The agency approved amivantamab for non-small cell lung cancer patients harboring EGFR exon 20 mutations, as detected by Guardant Health's blood-based test. Invitae, Pharma Firms Partner to Develop Standard MRD Panel for AML Clinical Trials Invitae is working with Bristol Myers Squibb, Janssen, Novartis, and Genentech to advance an NGS panel to gauge the efficacy of AML treatments in trials. Nonprofit Friends of Cancer Research Launches Public-Private HRD Harmonization Project The consortium aims to harmonize the use of homologous recombination deficiency as a biomarker to guide certain treatment types in cancer patients. UK Biobank Collaborating With Biopharmas to Profile Plasma Proteome of 53K Subjects Led by a group of 10 biopharmaceutical firms, the project will use Olink's proteomic technology to look at participants' plasma levels of roughly 1,500 proteins. Tempus, Janssen R&D Collaborate on Oncology Clinical Trial Matching Tempus is developing a new predictive bioinformatics model to improve clinical trial enrollment for Janssen, while the pharma firm has joined Tempus' TIME Trial. Sep 29, 2020 Sema4, Janssen Partner on Patient Identification for Cancer Clinical Trials Aug 12, 2020 GeneCentric Therapeutics, Janssen Partner to Uncover Bladder Cancer Biomarkers Jul 22, 2020 Alzheimer's Drug Discovery Foundation, Pharma Firms Form Biobank Alliance Jul 8, 2020 Guardant Health to Develop Liquid Biopsy Companion Diagnostic for Janssen NSCLC Therapy Apr 10, 2020 Free Bioinformatics Tool From Nference, Janssen Uncovers New COVID-19 Insights Mar 25, 2020 AmoyDx, Janssen Research and Development Partner on NGS-Based Companion Diagnostic Mar 12, 2020 Thermo Fisher, Janssen Biotech to Develop CDx for Lung Cancer, Other Indications Aug 28, 2019 HIV, SIV Protection Associated With Post-Vaccination Gene Expression Signature Jul 9, 2019 Celsius Therapeutics, Janssen Biotech Form Biomarker Discovery Alliance Jun 19, 2019 Resolution Bioscience, Janssen Partner to Develop CDx for Niraparib in Prostate Cancer Apr 26, 2019 European Project Aims to Develop Tools, Guidelines to Improve Data Sharing, Access Premium Apr 12, 2019 FDA Approves Qiagen Companion Dx for Bladder Cancer Drug Balversa Apr 9, 2019 Somalogic Collaborating With Janssen on Protein Biomarker Research Dec 12, 2018 BiomX Inks IBD Biomarker Deal With Janssen Nov 26, 2018 Proteomics International, Janssen Collaborating to Evaluate PromarkerD Kidney Disease Test Jun 14, 2018 Janssen Plans Year-End Erdafitinib Filing Based on Phase II Data in FGFR-Mutated Bladder Cancer Premium May 8, 2018 GenomeDx, Janssen Partner to Test Tumor Genome Profile Database Dec 6, 2017 Janssen to Evaluate Genomic Health GPS Test for Use in Prostate Cancer Drug Pipeline Nov 6, 2017 Adaptive Biotechnologies, Amgen Collaborate on Clinical Trial Oct 12, 2017 NIH Partners With Biopharmaceutical Firms on $215M Cancer Immunotherapy Research Initiative Load More Breaking News Alzheimer's Disease Phosphoproteomics Study Uncovers Signaling Abnormalities Genetic Analysis of H. Pylori Indicates Americas Colonized in One Main Migration Event BillionToOne Raises $55M in Series B Financing GeninCode to Launch Cardiovascular Disease Risk Tests in US With Eversana Top Five Articles on GenomeWeb Last Week: Illumina, Liquid Biopsy, Thermo Fisher Scientific, and More Becton Dickinson Sues Beckman Coulter Over Cell Analysis, Sorting IP The Scan Another Resignation According to the Wall Street Journal, a third advisory panel member has resigned following the US Food and Drug Administration's approval of an Alzheimer's disease drug. Novavax Finds Its Vaccine Effective Reuters reports Novavax's SARS-CoV-2 vaccine is more than 90 percent effective in preventing COVID-19. Can't Be Used The US Food and Drug Administration says millions of vaccine doses made at an embattled manufacturing facility cannot be used, the New York Times reports. PLOS Papers on Frozen Shoulder GWAS, Epstein-Barr Effects on Immune Cell Epigenetics, More In PLOS this week: genome-wide association study of frozen shoulder, epigenetic patterns of Epstein-Barr-infected B lymphocyte cells, and more.